AKAP12 and breast carcinoma: Among the predictions with the lowest scores, MTDH has been shown to epigenetically regulate TWIST1 and promote stemness in breast cancer [76] while AKAP12 has been suggested to protect ERK5 from PKCζ phosphorylation on residue S486A which inhibits its transcriptional activity [77].